Read the quarter in context.
A source-linked quarter view: reported numbers, management language, guidance, and the risks that should carry forward.
ConCallIQ research layer
Signal, with the source still visible.
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Revenue
₹1,029.8 Cr
verification pending
Revenue YoY
14.4%
reported change
EBITDA
₹118.1 Cr
latest reported figure
Source
bse pending
record provenance
Actual signal trajectory
Where this quarter sits.
Quarter read
What the record says.
Punjab Chemicals delivered a resilient FY26 with record revenue of ₹1,029.8 Cr (+14.4% YoY) and PAT of ₹64 Cr (+64.3% YoY), driven by stable volumes, new product contributions (14% of sales, growing 16% YoY), and improved capacity utilization (agrochemicals at 81%, industrial chemicals at 90%). Q4 saw gross margins expand 580bps YoY to 49.4% due to inventory build for the upcoming season, though EBITDA margin improved only modestly to 13.2% (+60bps). Management reiterated 15-20% revenue growth guidance for FY27, underpinned by new product ramp-up and three MoUs slated for commercialization. EBITDA margin target of 15% in 2-3 years remains intact. Key risk: further escalation in raw material costs from geopolitical tensions could pressure margins if price pass-through becomes difficult.
Colored figures show movement against the previous available record.
Guidance to track
- Management reaffirmed 15-20% YoY revenue growth guidance for FY27, driven by new product ramp-up and steady demand for existing products.
- Management targets improving EBITDA margin from ~12% to 15% over the next 2-3 years through product mix improvement and cost optimization.
- Planned capex includes ₹25-30 Cr maintenance, ₹20 Cr debottlenecking/compliance, and ₹60-80 Cr for a new production block.
- Management expects to finalize a greenfield land parcel and announce it within Q2 or Q3 of FY27.
Risks flagged
- Rising raw material and logistics costs due to geopolitical tensions could pressure margins if price pass-through becomes difficult.
- Management noted that while recent price hikes have been accepted, further increases may face customer resistance, potentially impacting volumes.
- Three MoUs slated for FY27 commercialization may face delays of a few months due to customer trials or geopolitical issues.
- Previous attempts to acquire land fell through due to legal issues; further delays could constrain growth beyond FY28-29.
Key quotes
- We are now moving from consolidation phase over the last 2-3 years to growth phase with our efforts to bring in new products have started yielding dividends.
- Unless and until this geopolitical situation suddenly creates a havoc where the raw materials are not available or some other things happen, we continue to hold our guidance of 15 to 20% year-on-year growth.
- So far customer has accepted the price increase... but if this increase becomes significantly higher than what it has been so far then we'll have to see overall how does the market react to it.
Research modules